siRNA藥物
Search documents
国泰海通晨报摘要-20251224
GUOTAI HAITONG SECURITIES· 2025-12-24 05:19
Group 1: Industry Research - The report highlights the emergence of small nucleic acid drugs, particularly siRNA, as a significant therapeutic avenue due to advancements in technology and expanding indications, marking the beginning of a new era in targeted therapy [5]. - Key domestic companies involved in the small nucleic acid drug sector include listed firms such as Yuyuan Pharmaceutical, Hengrui Medicine, and Shijiazhuang Pharmaceutical, as well as unlisted companies like Bowang Pharmaceutical and Ruibo Biotechnology [5]. Group 2: Company Tracking Report - Bertley (603596) - The report maintains a "Buy" rating for Bertley with a target price of 73.76 CNY, up from the current price of 51.10 CNY, reflecting a total market capitalization of 30,993 million CNY [6][7]. - Bertley's new product, the "small diameter caliper technology solution," is expected to enhance the company's market share in the braking sector, despite short-term pressures in the automotive industry [7]. - EPS forecasts for Bertley are projected at 2.34 CNY for 2025, 2.95 CNY for 2026, and 3.63 CNY for 2027, with a target PE of 25 times for 2026 [7]. Group 3: Company Tracking Report - Juneyao Airlines (603885) - The report recommends a "Buy" rating for Juneyao Airlines with a target price of 21.81 CNY, compared to the current price of 13.94 CNY, indicating a total market capitalization of 30,445 million CNY [10]. - The airline is expected to experience significant profit growth driven by industry recovery and fleet turnover, despite short-term impacts from maintenance issues [10]. - Net profit forecasts have been adjusted to 900 million CNY for 2025 and 1.6 billion CNY for 2026, with a long-term projection of 2.6 billion CNY for 2027, maintaining a target PE of 18 times for 2027 [10]. Group 4: Industry Biweekly Report - Food and Beverage - The report emphasizes growth as the main theme, focusing on supply-demand dynamics and potential turning points in the market [8]. - Recommendations include growth-oriented liquor brands such as Shanxi Fenjiu and Gujing Gongjiu, as well as stable stocks like Kweichow Moutai and Wuliangye [8]. - Structural growth in beverages is highlighted, with recommendations for brands like Dongpeng Beverage and Nongfu Spring, while also suggesting undervalued high-dividend stocks such as China Foods and Master Kong [8].